Our urgent goal — saving mind and sight through research

We drive innovative research worldwide and support awareness to end Alzheimer’s, macular degeneration, and glaucoma.
Learn more about our research

We're here to help.

Explore our tools, tips, and expert advice to help you understand, manage, and live with Alzheimer's disease, macular degeneration and glaucoma.

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me informed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.

Which brain or eye disease would you like to explore?

  • New Diagnosis?

    Managing a mind and sight disease is a journey. And you’re not alone. We can help.

    Take the first step
  • Expert

    Driving and Age-Related Macular Degeneration

    Many people with age-related macular degeneration (AMD) or their family members ask if it is safe to drive with this eye condition. This is an important and sometimes complex question that needs to take into consideration visual function, safety, and the person’s desire for independence.

    April 4, 2018
  • Two new medications hold great promise in lowering eye pressure by directly targeting the tissue that is diseased in glaucoma, the trabecular meshwork
    Expert

    Two New Glaucoma Medications: Learn More

    Learn about two new medications that were approved by the FDA in late 2017, and why they are so exciting to patients and ophthalmologists alike.

    March 14, 2018
  • This illustration of a head created from of clocks and gears relates to the fact that disturbances in the sleep-wake cycle and circadian rhythms (bodily processes that recur on a daily cycle) are common symptoms of Alzheimer disease.
    Expert

    Circadian Rhythms and Alzheimer’s Disease

    The word “circadian” refers to bodily processes that recur on a daily cycle, such as sleeping. This article discusses why disturbances in circadian rhythms are common symptoms of Alzheimer disease (AD).

    March 5, 2018

Everything you need to manage a brain or eye disease Go to the toolkit

  • This illustration of a head created from of clocks and gears relates to the fact that disturbances in the sleep-wake cycle and circadian rhythms (bodily processes that recur on a daily cycle) are common symptoms of Alzheimer disease.
    Expert

    Circadian Rhythms and Alzheimer’s Disease

    The word “circadian” refers to bodily processes that recur on a daily cycle, such as sleeping. This article discusses why disturbances in circadian rhythms are common symptoms of Alzheimer disease (AD).

    March 5, 2018

  • New Diagnosis?

    Managing a mind and sight disease is a journey. And you’re not alone. We can help.

    Take the first step
  • Wine being poured into a glass.
    Expert

    Alcohol and Dementia: A Complicated Relationship

    The role of alcohol use as a risk factor for dementia is complicated. At different times, alcohol has been seen as protective, harmful, or incidental to the risk of dementia. Each of these views is partially correct, and the entire story is not yet fully known. This article discusses some of what we do know.

    February 7, 2018

  • What happens to your brain duringAlzheimer's Disease?

    Track how nerve cells and the brain change from healthy to affected by mild and then severe Alzheimer's disease.
    View Infographic

Everything you need to manage a brain or eye disease Go to the toolkit

  • Expert

    Driving and Age-Related Macular Degeneration

    Many people with age-related macular degeneration (AMD) or their family members ask if it is safe to drive with this eye condition. This is an important and sometimes complex question that needs to take into consideration visual function, safety, and the person’s desire for independence.

    April 4, 2018
  • A patient talking with her eye doctor about what to expect now that she has a diagnosis of age-related macular degeneration.
    Expert

    What to Expect When You Receive the Diagnosis of AMD

    Many patients are frightened of losing vision or going blind when they are told they have age-related macular degeneration (AMD). Fortunately, most patients with AMD can keep good vision for their entire lives, and even those who lose their central vision almost always maintain their side, or “peripheral” vision.

    February 26, 2018

  • New Diagnosis?

    Managing a mind and sight disease is a journey. And you’re not alone. We can help.

    Take the first step

  • By 202040 million

    People will have visual impairments from advanced age-related macular degeneration (AMD).
    View Infographic

Everything you need to manage a brain or eye disease Go to the toolkit

  • Two new medications hold great promise in lowering eye pressure by directly targeting the tissue that is diseased in glaucoma, the trabecular meshwork
    Expert

    Two New Glaucoma Medications: Learn More

    Learn about two new medications that were approved by the FDA in late 2017, and why they are so exciting to patients and ophthalmologists alike.

    March 14, 2018

  • New Diagnosis?

    Managing a mind and sight disease is a journey. And you’re not alone. We can help.

    Take the first step
  • Secondary Glaucoma (Medications - Eye Disease - Trauma - Diabetes)
    Expert

    Secondary Glaucoma

    Secondary glaucoma is a broad term that encompasses many types of glaucoma that are the result of certain medical conditions in the eye or the body.

    February 12, 2018

  • More than3 million

    Americans aged 40 and older have glaucoma. It is estimated that the number will double to 6 million people by 2050.
    View Infographic

Everything you need to manage a brain or eye disease Go to the toolkit

Stories & Thanks

Connect with others who understand Join our community

Our Impact

We have one, important goal: to end brain and eye diseases in our lifetime.

Learn more

We support innovative science through our three programs:

  • Alzheimer’s Disease Research
  • Macular Degeneration Research
  • National Glaucoma Research
Learn more about our grants

Promising Science

  • Illustration showing amyloid plaques

    Can We Clear Toxic Proteins from the Brain? An Encouraging Breakthrough

    Research by BrightFocus grantee Matthew Campbell, PhD, of Trinity College Dublin, suggests a unique way to help clear the brain of toxic amyloid beta protein, which contributes to the development of Alzheimer’s.
  • Rendition of mineral, fat, and protein deposits in a cell.

    Scientists Uncover New Clues About How Macular Degeneration Forms

    An international research team has uncovered some clues to how age-related macular degeneration (AMD) begins, and their findings could lead to new avenues of research and early diagnosis.

  • Alzheimer’s in a Petri Dish

    In what is being hailed a “game changer” for Alzheimer’s research, researchers Rudolph E. Tanzi, PhD, and Se Hoon Choi, PhD, both BrightFocus grantees, have done the impossible. Together with their colleagues, they have managed to grow human brain cells in a laboratory for use in Alzheimer’s testing.
More science news

Help us find a cure. Give to BrightFocus

BrightFocus Updates